STAA analyst estimates
Staar Surgical (STAA) analyst ratings, the average price target and its range, and every firm's latest call.
STAA analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Sep 29, 2026 | Veritas Investment Research | Stifel Upgrades STAAR Surgical (STAA) to Buy | $31.00 |
| Sep 22, 2026 | Jefferies | Staar Surgical price target lowered to $23 from $28 at Jefferies | $23.00 |
| Aug 17, 2026 | UBS | STAAR Surgical (STAA) PT Lowered to $28 at Stifel After Net-Positive Earnings Call | $28.00 |
| Aug 13, 2026 | UBS | Staar Surgical price target lowered to $19 from $20 at UBS | $19.00 |
| Aug 13, 2026 | William Blair | Piper Sandler on STAAR Surgical (STAA): 'We Remain On The Sidelines' | $33.00 |
| Aug 13, 2026 | Jefferies | STAAR Surgical (STAA) PT Lowered to $28 at Jefferies | $28.00 |
| May 14, 2026 | Stifel Nicolaus | Staar Surgical price target raised to $31 from $18 at Stifel | $31.00 |
| May 14, 2026 | Piper Sandler | Staar Surgical price target raised to $33 from $16 at Piper Sandler | $33.00 |
| May 14, 2026 | Wedbush | Staar Surgical upgraded to Outperform from Neutral at Wedbush | $40.00 |
| May 14, 2026 | Canaccord Genuity | Staar Surgical price target raised to $32 from $27 at Canaccord | $32.00 |
| May 14, 2026 | Mizuho Securities | Staar Surgical price target raised to $27 from $22 at Mizuho | $27.00 |
| Apr 9, 2026 | Canaccord Genuity | Staar Surgical upgraded to Buy from Hold at Canaccord | $27.00 |
| Mar 4, 2026 | Stifel Nicolaus | STAAR Surgical (STAA) PT Lowered to $18 at Stifel After Noisy Q4 Results | $18.00 |
| Feb 9, 2026 | Stifel Nicolaus | Staar Surgical price target lowered to $19 from $28 at Stifel | $19.00 |
| Feb 3, 2026 | Wedbush | Staar Surgical initiated with a Neutral at Wedbush | $26.00 |
- 8 firms rate STAA: 4 buy, 3 hold, 1 sell.
- The average price target is $30.89 from 9 analysts, from $23.00 to $40.00.
Updated 2026-11-03 11:31 UTC